Dr. Leigh Sowerby, MD
Claim this profileSt. Joseph's Health Care
Studies Chronic Rhinosinusitis
Studies Prophylaxis of Nasal Polyps
6 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Leigh Sowerby, MD is currently running
Lebrikizumab
for Rhinosinusitis with Nasal Polyps
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The study will last about 18 months.
Recruiting1 award Phase 35 criteria
Dupilumab
for Nasal Polyps
The study aims to investigate the olfactory TDI score (Threshold, Discrimination, Identification) using the Sniffin' sticks test for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) on dupilumab. Twenty-seven adult patients will be followed up during the treatment with dupilumab on three visits to the Otolaryngology Clinic (Baseline, 3 months and 6 months). The primary endpoint will be the TDI score. Nasal polyp score, Quality of Olfactory Disorders - negative symptoms (QOD-NS symptom scores), SNOT-22 will be secondary endpoints.
Recruiting4 awards Phase 44 criteria
More about Leigh Sowerby, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Leigh Sowerby, MD has experience with
- Placebo
- Dupilumab
- Depemokimab (GSK3511294)
- Novapak Nasal Sinus Packing And Stent
- Lebrikizumab
- Stellate Ganglion Block
Breakdown of trials Leigh Sowerby, MD has run
Chronic Rhinosinusitis
Prophylaxis of Nasal Polyps
Olfactory Disorders
Nasal Polyps
Nasal Obstruction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Leigh Sowerby, MD specialize in?
Leigh Sowerby, MD focuses on Chronic Rhinosinusitis and Prophylaxis of Nasal Polyps. In particular, much of their work with Chronic Rhinosinusitis has involved treating patients, or patients who are undergoing treatment.
Is Leigh Sowerby, MD currently recruiting for clinical trials?
Yes, Leigh Sowerby, MD is currently recruiting for 3 clinical trials in London Onterio. If you're interested in participating, you should apply.
Are there any treatments that Leigh Sowerby, MD has studied deeply?
Yes, Leigh Sowerby, MD has studied treatments such as Placebo, Dupilumab, Depemokimab (GSK3511294).
What is the best way to schedule an appointment with Leigh Sowerby, MD?
Apply for one of the trials that Leigh Sowerby, MD is conducting.
What is the office address of Leigh Sowerby, MD?
The office of Leigh Sowerby, MD is located at: St. Joseph's Health Care, London, Onterio N6A 4V2 Canada. This is the address for their practice at the St. Joseph's Health Care.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.